Last updated: 2026-09-16 10:31:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Intelligent Bio Solutions Inc. (INBS) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2,01, with a market capitalisation of $6,27M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,52 to $24,90. This page covers its latest market performance, valuation, price trends and company information.
$6,27M | |
$2,06 | |
$3.840,00 | |
$1,52 | |
$2,05 | |
480,00 | |
159,98K | |
-- | |
$24,90 | |
$1,52 | |
-- | |
-- |
Intelligent Bio Solutions Inc. (INBS) is trading at $2,01 in pre-market trading as of 2026-09-16 09:54:00, down 2,20% ($0,04) from the previous close of $2,05
Pre-market trading shows how investors are pricing INBS before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Intelligent Bio Solutions Inc. (INBS) moved from $2,23 to $2,01, representing a decline of 10,09% ($0,23).
The stock traded between $2,01 and $2,40 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 50,90 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 2,1%
INBS is currently trading at $2,01, placing it 2,1% of the way from its 52-week low of $1,52 to its 52-week high of $24,90. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 60 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Intelligent Bio Solutions Inc. (INBS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.